REX AI Equity Premium Income ETF (NASDAQ: AIPI)

에 대한 최신 뉴스 REX AI Equity Premium Income ETF (NASDAQ:AIPI)

Technology

Real Estate

Consumer Cyclical

The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities comprising the BITA AI Leaders Select Index (the Index). The Fund is an actively managed exchange-traded fund (ETF) that seeks capital appreciation and current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the securities of the companies comprising the Index, subject to a potential reduction in returns in a rising market.

Palantir Technologies Inc.

Arm Holdings Plc 0.00000000

NVIDIA Corporation

Crowdstrike Holdings Inc. Class A

Datadog Inc. Class A

Arista Networks, Inc

ADOBE SYSTEMS INC

Broadcom, Inc

Palo Alto Networks Inc.

International Business Machines Corp.

Meta Platforms, Inc.

Qualcomm Inc.

Synopsys Inc.

Alphabet Inc

Amazon.Com Inc

Super Micro Computer, Inc.

Apple Inc

Cisco Systems Inc

REX AI Equity Premium Income ETF

alex karp palantir flickr2

Equities

News

Markets

ETFs

General

AIPI

ARKK

PLTR

SHLD

팔란티어 테크놀로지스(NASDAQ:PLTR)의 주가가 올해 초 대비 298.37% 상승하여 현재로서 주목받고 있다. 이 급등은 팔란티어에 상당한 노출을 가진 ETF에 대한 관심을 불러일으켰다.

팔란티어의 연간 수익률 급등 298%: 알렉스 카프의 회사에 노출된 ETF의 성과는?

palantir shutter

Long Ideas

Broad U.S. Equity ETFs

Tech

Trading Ideas

팔란티어 테크놀로지스(NYSE:PLTR)는 11월 26일부터 NYSE에서 나스닥 글로벌 선택 시장으로의 이전을 준비 중다. 이것이 향후 나스닥-100 지수 포함을 위한 한 단계가 될까?

나스닥 100 리밸런스가 다가오는 가운데 팔란티어에 노출을 갖는 고려해 볼 ETF 3가지

Wells Fargo analyst Ken Gawrelski maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Equal-Weight and lowers the price target from $14 to $13.

Price Target

Analyst Ratings

LYFT

Wells Fargo Maintains Equal-Weight on Lyft, Lowers Price Target to $13

WIIM

Citizens Financial Group shares are trading lower after JP Morgan cut its price target on the stock from $49 to $43.

Wells Fargo analyst Ken Gawrelski maintains DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) with a Equal-Weight and raises the price target from $198 to $201.

DASH

Wells Fargo Maintains Equal-Weight on DoorDash, Raises Price Target to $201

OSR Holdings, Inc. ("OSR") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>), a global healthcare company focused on advancing innovative therapies, today announced that it has entered into a Common Stock Purchase Agreement with White Lion GBM Innovation Fund ("Innovation Fund"). Under this agreement, OSR has the right, but not the obligation, to sell up to $80 million in common stock to Innovation Fund over time, which will prospectively provide OSR with critical funding to accelerate its mission of improving patient outcomes worldwide.

Offerings

OSRH

OSR Holdings Enters $80M Common Stock Purchase Agreement With White Lion GBM Innovation Fund To Secure Funding For Advancing Innovative Therapies And Improving Patient Outcomes Globally

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.09% on an annualized basis producing an average annual return of 9.0%. Currently, AptarGroup has a market capitalization of $9.93 billion. 
Buying $100 In ATR: If an investor had bought $100 of ATR stock 20 years ago, it would be worth $563.42 today based on a price of $150.53 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743689768_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Toast's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) short percent of float has fallen 12.43% since its last report. The company recently reported that it has 23.58 million shares sold short, which is 4.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Toast Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743689728_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Toast has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Toast's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Toast's peer group average for short interest as a percentage of float is 5.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

TOST

Is Toast Gaining or Losing Market Support?

Weyerhaeuser's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) short percent of float has risen 24.48% since its last report. The company recently reported that it has 10.82 million shares sold short, which is 1.78% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Weyerhaeuser Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743689723_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Weyerhaeuser has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Weyerhaeuser's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Weyerhaeuser's peer group average for short interest as a percentage of float is 5.00%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Weyerhaeuser?

For many investors, dividend-focused <a href="https://in.benzinga.com/25/03/44565770/30-year-old-with-65k-in-stocks-sparks-debate-focusing-mostly-on-etfs-but-now-betting-on-bonds-small-caps-and-international-plays">stocks</a> and funds provide a way to generate passive income, whether to supplement retirement, cover day-to-day <a href="https://in.benzinga.com/personal-finance/25/02/43768530/should-married-couples-split-expenses-dave-ramsey-says-no-youre-married-not-roommates">expenses</a>, or even finance small luxuries like annual vacations.
While some aim for significant <a href="https://in.benzinga.com/personal-finance/25/03/44518501/20-year-old-university-student-wants-help-with-buying-dividend-stocks-whats-the-best-way-to-start-reddit-weights-in">dividend</a> payouts to replace their salary, others are happy with modest but constant returns that offer a little extra financial freedom.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>
This is the case of a Reddit user who is exploring this approach. With $30,000 to invest, he's seeking long-term dividend stocks that can grow over the next 20 years until retirement. While he already holds dividend-paying stocks like Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Walt Disney&nbsp; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), he wants to expand his portfolio for stability and future income, even if it's just enough to cover yearly vacations.
&#8220;I currently have some stocks that give out dividends (Apple, Disney) but I&#8217;m looking for others. Long-term stability, that my wife and I can use the dividends as another form of income say in 20 years. Even if it&#8217;s just enough to pay for a yearly vacation here or there. Any thoughts on good companies to choose from?&#8221; he asked.
Let&#8217;s break down the Redditors&#8217; advice received in the comment section.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">Where to Invest $30,000 to Generate Enough Income to Cover Yearly Vacations? Reddit Answers</h2>
Put the Money in an ETF
Several commenters recommended Schwab U.S. Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>) as a core holding because of its dividend yield, historical growth, and the low-risk, diversified exposure it offers investors.
&#8220;Go all in SCHD. Low risk, nice 3.5% starting yield and it will just keep growing,&#8221; a commenter said.
Reinforcing the idea that SCHD fits the poster&#8217;s long-term stability and dividend payout need, this Redditor also suggested he goes with SCHD: &#8220;Since you want some growth and decent payout, SCHD is a great option. 3.5% dividends and 11% growth over the last 10 years each year.&#8221;
&#8220;I would stick with S&amp;P 500 ETFs being young. Put it in a self-direct investment retirement account to avoid taxes,&#8221; a comment reads.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Consider High-Yield Dividend Stocks and Trusts
Several commenters suggested higher-yield assets that would generate higher payouts for the investor in the long run.
&#8220;If you want higher yield stocks check: [Verizon Communications (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vz#NYSE">VZ</a>)], [AT&amp;T (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/t#NYSE">T</a>)], [Realty Income Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/o#NYSE">O</a>)], [Altria Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>)], [British American Tobacco (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bti#NYSE">BTI</a>)],&#8221; a Redditor recommended.
A commenter mentioned United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) as a great pick since the company seems to start focusing on higher profit margin areas.
&#8220;UPS pays a solid dividend and the share price has been beaten down a lot on the news that they are reducing Amazon deliveries to focus on higher profit margin areas,&#8221; he said.
Suggesting a very detailed portfolio allocation, this Redditor mentioned several ETFs and individual stocks that he considers would help the poster reach his dividend and growth goals.
&#8220;[Vanguard S&amp;P 500 ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/voo#NYSE">VOO</a>)] $5,000, 1.25% dividends. Do [dividend reinvestment plan] SCHD $5,000, 3.5% dividends. Do [dividend reinvestment plan], [JPMorgan Equity Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jepi#NYSE">JEPI</a>)], [JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jepq#NASDAQ">JEPQ</a>)​] ($5,000), 8% combined dividends. Do [dividend reinvestment plan] [Old Republic International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ori#NYSE">ORI</a>)] $2,000, 3% dividends. Do [dividend reinvestment plan] [Waste Management (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wm#NYSE">WM</a>)] and [Automatic Data Processing (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adp#NASDAQ">ADP</a>)] ($3,000), 2% average dividend. Do [dividend reinvestment plan] [Pfizer (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>)] and [Johnson &amp; Johnson (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>)] $2,000, 4.75% average dividend. Do [dividend reinvestment plan] [JPMorgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>)] and [UnitedHealth Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>)] $2,000, 2% average dividends. Do [dividend reinvestment plan] AAPL and [Microsoft (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>)] $2,000. [The Coca-Cola Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>)] and MO $2,000, 5% average dividends. Do [dividend reinvestment plan] JPM or [American Express (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axp#NYSE">AXP</a>)] $2,000. JPM has good potential growth,&#8221; the suggestion says.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Personal Finance

AAPL

JEPI

JEPQ

MSFT

SCHD

Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts

MPLX's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>) short percent of float has fallen 5.79% since its last report. The company recently reported that it has 9.13 million shares sold short, which is 2.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.7 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>MPLX Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743689718_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MPLX has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MPLX's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MPLX's peer group average for short interest as a percentage of float is 4.48%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MPLX

Is the Market Bullish or Bearish on MPLX?

Wells Fargo analyst Eric Luebchow maintains Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) with a Overweight and lowers the price target from $215 to $200.

Wells Fargo Maintains Overweight on Dycom Industries, Lowers Price Target to $200

Invesco shares are trading lower after B of A Securities cut its price target on the stock from $19 to $18.

Guggenheim analyst Michael Morris reiterates Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Buy and maintains $1100 price target.

Reiteration

NFLX

Guggenheim Reiterates Buy on Netflix, Maintains $1100 Price Target

Synchrony Financial shares are trading lower after Wells Fargo cut its price target on the stock from $85 to $70.

Resources Connection shares are trading lower after the company reported worse-than-expected Q3 sales results.

&ldquo;Every dog owner has the goal of increased longevity with their dogs,&rdquo; says Leslie Mosier, displaying the passion of a devoted pet parent. This sentiment is at the heart of why she, alongside her partner Rob Chianelli, launched Nonipup, a brand born from necessity and nurtured through personal challenges and triumphs.
Leslie&rsquo;s journey into the pet wellness industry was precipitated by Doug the Pug&#39;s severe health scare. &ldquo;I then realized I had to work on my dog&rsquo;s own prevention and lifestyle as I was personally responsible for it,&rdquo; she explains.
Witnessing Doug&#39;s health issues firsthand transformed her perspective on pet care, mirroring her own health struggles with endometriosis and her husband&#39;s battle with multiple sclerosis. &ldquo;We had to &lsquo;clean up&rsquo; our home,&rdquo; Leslie explains, highlighting the revelation they had about harmful ingredients found both in human products and those meant for their canine companions. This epiphany led to Nonipup, a testament to their commitment to quality, safety and the well-being of pets.
<h3>Doug The Pug&rsquo;s CBD Predilection</h3>
The introduction of <a href="https://elplanteo.com/que-es-el-cbd/">CBD</a> into Nonipup&rsquo;s product line was a natural progression, driven by an acknowledgment of its therapeutic benefits. &ldquo;CBD and other beneficial cannabinoids offer so many benefits to our pets,&rdquo; Leslie notes. She elaborates on its effectiveness in alleviating issues such as joint pain, mobility problems and anxiety, particularly among aging dogs. Ensuring the highest standards for these products, Nonipup employs a rigorous formulation process. Ian Pedersen, the company&rsquo;s director of medical hemp CBD research, brings more than 24 years of experience in the hemp and cannabis industries. &ldquo;The amount of time, research and forethought put into formulating Nonipup CBD products were the keys to allowing us to bring such an impactful product to the pet community,&rdquo; Leslie says.
Also read:&nbsp;<a class="post-card-article-link" href="https://www.benzinga.com/markets/cannabis/25/04/42205205/gary-payton-wants-you-to-rethink-cannabis-its-about-mental-health-it-brought-my-mom-back-in-her-">Gary Payton Wants You To Rethink Cannabis: &#39;It&#39;s About Mental Health&hellip; It Brought My Mom Back In Her Final Days&#39;</a>
This rigorous development is further supported by Rita Hogan, a top canine herbalist, who formulated some of Nonipup&rsquo;s salves and products. Her extensive knowledge and expertise have been instrumental in creating effective and safe wellness solutions for pets.
<img alt="Doug &amp; Nonipup" src="https://imageio.forbes.com/specials-images/imageserve/66426c92d9e59d9dca189ef2/Doug---Nonipup/960x0.jpg?format=jpg&amp;width=1440" style="height:450px; width:300px" />
Doug &amp; Nonipup. SWAK PHOTOGRAPHY
The global pet care market is&nbsp;<a href="https://videnglobe.com/blog/how-to-boost-your-pet-shop-sales-with-effective-marketing-strategies" rel="nofollow noopener noreferrer" target="_blank" title="https://videnglobe.com/blog/how-to-boost-your-pet-shop-sales-with-effective-marketing-strategies">projected</a>&nbsp;to reach $241 billion by 2026, with a growing segment dedicated to natural wellness products like CBD. &ldquo;The demand is incredibly high for holistic dog products that are safe and effective,&rdquo; Leslie observes. As&nbsp;<a href="https://www.waxmancancer.org/about-us/newsroom/press-releases/cancer-rates-in-dogs-rising-due-to-longer-lifespans/" rel="nofollow noopener noreferrer" target="_blank" title="https://www.waxmancancer.org/about-us/newsroom/press-releases/cancer-rates-in-dogs-rising-due-to-longer-lifespans/">cancer rates rise among dogs</a>, pet owners are increasingly seeking trustworthy, natural alternatives to traditional pharmaceuticals.
Yet, Leslie and her team are navigating the complex regulatory landscape surrounding CBD products with a focus on education and transparency. &ldquo;With the implementation of the Agricultural Innovation Act of 2019 known as the Hemp Act, it has allowed for the deregulation of the hemp plant and its extracts across the nation,&rdquo; Leslie explains. This legislative groundwork has been crucial in ensuring that Nonipup&rsquo;s products are both legal and beneficial. Beyond compliance, Nonipup is committed to setting industry standards that prioritize pet wellness over profit.
<h3>Leading The Charge On Pet Wellness Education</h3>
Nonipup&#39;s commitment to education extends beyond its products. The team actively works to challenge the stigma associated with cannabis products for pets by highlighting the safe and beneficial aspects of CBD. &ldquo;We continue to educate health professionals and organizations across the country,&rdquo; Leslie says. This educational drive is vital in transforming perceptions and enhancing the acceptance of cannabis in pet wellness.
The company also leverages the power of social media, sharing educational content and engaging with both celebrities and everyday pet owners to build trust and credibility. Doug the Pug&rsquo;s vast social media following (more than half a billion views on YouTube, 6.1 million TikTok followers, 5.6 million Facebook followers, 3.6 million Instagram followers and 2.5 million X/Twitter followers) significantly boosts Nonipup&#39;s brand recognition and consumer trust.
Also read:&nbsp;<a class="post-card-article-link" href="https://www.benzinga.com/markets/cannabis/25/04/42205176/weve-accepted-mommy-wine-culture-why-not-cannabis-meet-the-woman-behind-the-largest-weed-pr-firm">&#39;We&#39;ve Accepted Mommy-Wine Culture; Why Not Cannabis?&#39;&mdash;Meet The Woman Behind The Largest Weed PR Firm In North America</a>
What&rsquo;s more, the team&rsquo;s dedication to education is evident in its comprehensive approach to informing pet owners. The company sends a newsletter with weekly health tips and plans to expand its educational initiatives by collaborating with veterinary professionals, CBD experts like Ian Pedersen and animal behaviorists. This commitment helps the team address one of the significant challenges in the industry: building awareness and understanding about the benefits of cannabis-based products in pet care.
Leslie emphasizes the importance of these collaborations, particularly with veterinarians. &ldquo;Ian Pedersen has been educating hundreds of veterinary professionals through his educational lectures across the country,&rdquo; she says. This joint effort ensures that Nonipup&#39;s products are not only effective but also trusted by professionals in the field. By working closely with health experts, Nonipup strengthens the integrity of its formulations and fosters trust among pet owners.
One of the most heartwarming aspects of Nonipup&#39;s journey has been the feedback from pet owners. Leslie shares a touching story: &ldquo;A pet owner reached out to tell us that after starting their dog on our CBD oil, the dog&#39;s mysterious nightly spasms stopped. They were so relieved they could avoid the high costs and stress of further medical tests.&rdquo;
Leslie beams with pride as she recounts the success stories. &ldquo;Our customers often tell us they see a difference not just in their pets&rsquo; physical health, but in their demeanor. It&rsquo;s like they get their spirit back,&rdquo; she voices. This positive feedback has been overwhelming, with many attributing their pets&#39; renewed vitality to Nonipup&#39;s range. From resolving chronic skin issues with its Boop Butter to enhancing mobility with its CBD oil, the results speak volumes.
<h3>Challenging The Stigma</h3>
Leslie is actively working to help people overcome the stigma associated with cannabis products for pets. She emphasizes the safe and beneficial aspects of CBD, supported by studies and expert collaborations. &ldquo;Our initial studies and success cases with our research team began with humans, which gave us a great baseline understanding for the benefits of CBD,&rdquo; she explains. This foundational knowledge has been instrumental in addressing skepticism and demonstrating the efficacy of CBD for pets.
<img alt="Doug &amp; Nonipup" src="https://imageio.forbes.com/specials-images/imageserve/66426cada9e030d50918eda3/Doug---Nonipup/960x0.png?format=png&amp;width=1440" style="height:450px; width:296px" />
Doug &amp; Nonipup. COURTESY OF NONIPUP
By isolating conditions that CBD can support, Nonipup has been able to share its findings widely with the pet community. &ldquo;We are committed to leading the charge on CBD and cannabinoid research for both pets and pet parents,&rdquo; Leslie says. This commitment to research and education is crucial in changing perceptions and fostering acceptance of cannabis in pet wellness.
The role of celebrity pets like Doug the Pug in shaping pet care trends and consumer behaviors cannot be understated. Leveraging Doug&rsquo;s popularity helps promote trusted products and drive positive change in the pet wellness industry.
Nonipup&rsquo;s proactive approach to navigating the regulatory landscape and addressing the stigma surrounding cannabis products highlights its dedication to advancing pet wellness. As the team continues to innovate and educate, Nonipup is setting a precedent for transparency and quality in the industry. The journey of Nonipup is not just about selling products; it&rsquo;s about advocating for a shift in how pet health is managed, emphasizing prevention and natural remedies over reactionary measures.
<h3>Innovating For Tomorrow: Nonipup&#39;s Vision For The Future</h3>
Leslie outlines Nonipup&#39;s vision to seamlessly blend pet wellness with cannabis. Its mission is to continue developing high-quality products for both pets and pet parents, promoting health and wellness through education and innovation.
This strategy appeals to a growing number of pet owners who are increasingly conscious of the ingredients in their pets&#39; products. The demand for natural and holistic pet care solutions has driven Nonipup to expand its offerings, including upcoming products like wrinkle wipes, gut-soothing supplements and anti-allergy tinctures.
Navigating the complexities of the CBD market, Nonipup is committed to industry leadership, which is vital in an environment where misinformation can easily influence consumer choices.
Leslie highlights the broader impact of Nonipup in the pet care industry, focusing on their dedication to quality and education. &ldquo;We&rsquo;ve seen a shift in how people approach pet care. They&rsquo;re more discerning about what they buy and more proactive about prevention,&rdquo; she observes.
Collaborations with veterinarians and pet care professionals ensure Nonipup&#39;s products align with the latest in animal health science. These partnerships are crucial for maintaining the integrity of their formulations and driving responsible innovation. &ldquo;Working closely with health experts not only improves our products but also strengthens the trust our customers place in us,&rdquo; Leslie notes.
Looking ahead, Nonipup plans to expand its reach and continue to innovate. With new products on the horizon and plans to enter additional markets, the potential for growth is significant. Future ventures may include eco-friendly pet accessories and advanced nutritional supplements.
Through thoughtful innovation and a genuine commitment to pet health, Nonipup seeks to create more than a brand, its intent is to spearhead a movement toward a future where pet wellness is prioritized and embraced as an integral part of family life. As Leslie and her team push the boundaries of pet care, Nonipup&rsquo;s journey continues to be a source of hope and inspiration for pet owners worldwide.
Follow me on&nbsp;<a href="https://www.twitter.com/javierhasse" rel="nofollow noopener noreferrer" target="_blank">Twitter</a>&nbsp;or&nbsp;<a href="https://www.linkedin.com/in/javierhasse/" rel="nofollow noopener noreferrer" target="_blank">LinkedIn</a>.&nbsp;Check out&nbsp;my&nbsp;<a href="https://elplanteo.com/" rel="nofollow noopener noreferrer" target="_blank">website</a>&nbsp;or&nbsp;some of my other work&nbsp;<a href="https://benzinga.com/cannabis" rel="nofollow noopener noreferrer" target="_blank">here</a>.&nbsp;
Photos courtesy of&nbsp;Nonipup.
This article was originally published on <a href="https://www.forbes.com/sites/javierhasse/2024/05/13/how-viral-dog-doug-the-pugs-health-scare-sparked-creation-of-pet-cbd-line-they-get-their-spirit-back/">Forbes</a> and appears here with permission.&nbsp;The article is from an external source. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Cannabis

When Viral Icon Doug The Pug Got Sick, His Family Created A Cannabis Brand: 'CBD Offers Real Benefits For Pets'

Wells Fargo analyst Michael Sison maintains Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) with a Equal-Weight and lowers the price target from $400 to $380.

Wells Fargo Maintains Equal-Weight on Sherwin-Williams, Lowers Price Target to $380

Wells Fargo analyst Michael Sison maintains PPG Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) with a Overweight and lowers the price target from $135 to $130.

Wells Fargo Maintains Overweight on PPG Indus, Lowers Price Target to $130

Stantec Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STN#NYSE">STN</a>), a sustainable engineering, architecture, and environmental consulting company, announced Thursday that it has signed a definitive agreement to acquire Page, a 1,400-person architecture and engineering firm headquartered in Washington, D.C. Financial<a href="https://www.benzinga.com/pressreleases/25/04/g44623995/stantec-to-acquire-page-a-us-based-full-service-design-architecture-and-engineering-firm"> terms were not disclosed.</a>
Founded in 1898 in Austin, Texas, Page has offices in 20 cities across the U.S. and Mexico.
Stantec&nbsp;noted the acquisition makes it the second-largest U.S. architecture firm and expands its reach in high-growth sectors like healthcare, data centers, advanced manufacturing, and cleanroom design. It also reinforces Stantec&#8217;s 2024–2026 Strategic Plan and broadens its presence across civic, academic, and commercial markets.
Post-close, the company expects to maintain its target net debt to adjusted EBITDA range of 1.0x to 2.0x. The deal will grow Stantec&#8217;s U.S. Buildings practice by about 35% and increase its U.S. workforce to roughly 13,500.
&#8220;This acquisition will greatly support our strategic market growth in our Buildings business while enabling us to leverage our expanded platform to better serve our North American clients and grow our worldwide market presence,&#8221; said Gord Johnston, Stantec president and CEO.
Page&#8217;s&nbsp;signature projects include Austin&#8217;s 36-story Indeed Tower, NYU&#8217;s John A. Paulson Center, and the National Museum of African American History and Culture.
Stantec plans to fund the acquisition through existing cash and credit facilities. As of December 31, 2024, Stantec held cash and cash equivalents of <a href="https://www.stantec.com/content/dam/stantec/files/investor-relations/2024/stantec-2024-annual-report.pdf" target="_blank" rel="noreferrer noopener">$228.5 million</a>.
Price Action: STN shares traded higher by 1.38% at $86.44 at last check Thursday.
Photo via Shutterstock.

Stantec Makes Power Move With Page Acquisition, Eyes Top Spot In US Architecture

Wells Fargo analyst Michael Sison maintains Axalta Coating Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXTA#NYSE">AXTA</a>) with a Equal-Weight and lowers the price target from $45 to $42.

AXTA

Wells Fargo Maintains Equal-Weight on Axalta Coating Systems, Lowers Price Target to $42

Sensata Technologies shares are trading lower after Evercore ISI Group downgraded the stock from Outperform to In-Line and cut its price target from $40 to $27.

Press Releases

REX Shares Launches New Covered Call ETF Targeting AI Market Leaders for Enhanced Income Opportunities

REX Shares Unveils Latest Covered Call ETF Designed to Enhance Exposure to Crypto Leaders

CEPI

FEPI

팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)의 주가가 올해 초 대비 298.37% 상승하여 현재로서 주목받고 있다. 이 급등은 팔란티어에 상당한 노출을 가진 ETF에 대한 관심을 불러일으켰다.
<a href="https://pro.benzinga.com/" target="_blank" rel="noopener">벤징가 프로</a>에 따르면, Global X Defense Tech ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>)는 포트폴리오의 7.82%를 팔란티어 주식에 투자하여 약 5,185만 달러에 해당하는 124만 주를 보유하고 있다. SHLD는 팔란티어의 방산 및 정보 분야 존재와 다른 항공우주 및 방산 기업들을 결합한 ETF로, 올해 초 대비 40.86% 상승한 실적을 기록했다.
한편, ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)는 포트폴리오의 거의 5%를 팔란티어에 할당하여 2억 7,300만 달러 이상을 653만 주에 투자했다. 고성장 기업들을 지원하는 것으로 알려진 ARKK는 60억 달러 이상의 운용 자산을 보유하고 있으며, 올해 초 대비 13.17% 상승한 실적을 기록했다.
반면, REX AI Equity Premium Income ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIPI#NASDAQ">AIPI</a>)는 팔란티어에 9.46% 노출되어 있으며, 924만 달러 규모의 포지션을 가지고 있다. 그러나 AIPI의 올해 초 대비 수익률은 0.61% 감소했다. AIPI는 아웃 오브 더 머니 커버드 콜 옵션을 매도하여 수익을 창출하지만, 자본 증가를 제한할 수 있는 전략을 사용한다.
작성 시점에 팔란티어의 주가는 수요일 정규 거래에서 0.47% 오른 66.05달러에 마감했다. 이후 시간외 거래에서 0.23% 상승했다. 최근 분석가들의 팔란티어에 대한 평가가 BofA 증권, 웨드부시 및 골드만삭스에 의해 각각 11월 25일과 11월 7일에 발행되었으며, 이들 기관의 평균 목표 주가가 63.67달러로 설정되었다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28083739/Screenshot-2024-11-28-at-7.07.26%E2%80%AFPM-1024x390.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
면책 조항: 이 콘텐츠는 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">Benzinga Neuro</a>의 도움으로 부분적으로 제작되었으며 Benzinga 편집자가 검토하고 게시했습니다.
Image via Flickr
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

팔란티어 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)는 11월 26일부터 <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42014351/palantir-prepares-nasdaq-move-could-nasdaq-100-be-next">NYSE에서 나스닥</a> 글로벌 선택 시장으로의 이전을 준비 중다.
이것이 향후 나스닥-100 지수 포함을 위한 한 단계가 될까?
투자자들은 이 주식의 상장지수펀드(ETF) 노출에 주목하고 있으며, 특히 나스닥-100 포함 가능성으로 인해 가시성과 시장 가치가 상승함에 따라 주목하고 있다.
또한 읽어보세요: <a href="https://www.benzinga.com/24/11/42094248/trumps-return-boosts-palantir-national-security-bets-drive-140-billion-market-cap">팔란티어 테크의 1,400억 달러 시가총액 증가가 트럼프의 승리와 국방비 증가 기대에 의해 주도 &#8211; 주식이 고평가되었나?</a>
PLTR 주식에 대한 확고한 노출을 가진 세 가지 ETF를 소개한다. 우리는 투자자들이 고려할 수 있는 적절한 노출과 좋은 유동성을 제공할 수 있는 ETF를 선택했다.
<h3 class="wp-block-heading">REX AI Equity Premium Income ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIPI#NASDAQ">AIPI</a>)</h3>
AIPI 포트폴리오는 PLTR 주식에 9.46% 노출되어 있으며, 이는 팔란티어에 대한 924만 달러의 포지션으로 환산된다. 이 ETF는 로봇공학과 인공지능(AI)에 중점을 두고 있으며, 이는 팔란티어의 기술 주도 솔루션과 잘 맞아떨어진다.
상당한 노출로 인해 AIPI는 팔란티어의 성장 잠재력에 대한 강력한 베팅을 제공한다. ETF의 25.38억 달러 AUM(운용 자산)으로 인해 적절한 유동성을 보장한다.
<h3 class="wp-block-heading">Global X Defense Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>)</h3>
SHLD 포트폴리오는 PLTR 주식에 7.82% 노출되어 있어, 다양한 방산 기술 ETF를 찾는 투자자들에게 적절한 비율이다. 이 ETF는 팔란티어의 방산 및 정보 분야의 존재와 항공우주 및 방산의 기타 주요 플레이어들을 결합한다.
430.87백만 달러의 AUM을 보유한 이 펀드는 유동성을 잘 유지하면서 투자자들에게 안정적인 팔란티어 주식의 일부를 제공한다.
<h3 class="wp-block-heading">ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)</h3>
팔란티어는 ARKK에서도 두각을 나타내며, 포트폴리오의 거의 5%를 PLTR 주식에 할당했다. 2억 7,300만 달러 이상이 팔란티어 주식에 투자된 653만 주를 보유하고 있는 ARKK는 혁신 분야에서 강한 위력을 발휘하며 고성장 기업을 지원하는 것으로 알려져 있다. 이 펀드는 60억 달러 이상의 AUM을 보유하여 투자 유동성을 보장한다.
팔란티어에 대한 노출은 기술 중심의 포트폴리오에 적절히 맞아떨어지며, 이 ETF의 규모와 유동성은 팔란티어의 미래 잠재력에 투자하려는 투자자들에게 여전히 유효한 옵션이 된다.
팔란티어가 나스닥 상장과 나스닥-100 편입 가능성에 가까워짐에 따라, 이러한 ETF들은 투자자들에게 회사에 대한 노출을 얻을 수 있는 기회를 제공한다.
상당한 PLTR 주식 노출과 강력한 유동성을 가진 이 펀드들은 팔란티어의 잠재적 성장에 투자하려는 이들에게 스마트한 선택이 될 수 있다.

다음 읽어보기:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/24/11/42058235/palantir-board-member-in-a-deleted-x-post-said-nasdaq-move-will-force-billions-in-etf-buying-and-deliver-tendies-heres-what-this-meme-stock-term-means">팔란티어 이사회 위원이 삭제된 X 포스트에서 나스닥 이동이 &#8216;수십억 달러의 ETF 매수를 강요하고, 텐디를 제공할 것&#8217;이라고 말했다. 이 밈 주식 용어의 의미는 무엇인가?</a></li>
</ul>
이미지: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

REX AI Equity Premium Income ETF

뉴스

에 대한 최신 뉴스 REX AI Equity Premium Income ETF (NASDAQ:AIPI)

금요일, 11월 29, 2024

토요일, 11월 23, 2024

뉴스

파트너 / 기고자

벤징가 글로벌